-
-
-
-
-
-
-
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results
-
-
-
-
-
-
-
Simulations Plus Invests in Clinical Development Technology Company Nurocor
-
-
-
-
-
-
-
Simulations Plus (SLP) Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions
-
-
-
-
-
-
-
Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum
-
-
-
-
-
-
-
Simulations Plus (SLP) Acquires Immunetrics
-
-
-
-
-
-
-
Simulations Plus (SLP) Reports Q1 Revenues of $12.4M, Diluted EPS of $0.15
-
-
-
-
-
-
-
Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer
-
1,182,407 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

